NIH Guide: Weekly Index for August 14, 2020

Funding Opportunities

• NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
  (PAR-20-259)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): November 2, 2020; October 14, 2021; October 14, 2022
• Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
  (PAR-20-263)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply The first standard application due date for this FOA is October 5, 2020.
• Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
  (PAR-20-264)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is October 16, 2020.
• Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)
  (PAR-20-284)
  National Cancer Institute
  Application Receipt Date(s): November 4, 2020, May 6, 2021, November 4, 2021, May 5, 2022, November 3, 2022, May 4, 2023
• Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
  (RFA-AG-21-021)
  National Institute on Aging
  Application Receipt Date(s): February 3, 2021, October 22, 2021, and October 21, 2022, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
• Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)
  (RFA-CA-20-052)
  National Cancer Institute
  Application Receipt Date(s): November 18, 2020 No late applications will be accepted for this FOA.
• Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required)
  (RFA-DK-20-003)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 1, 2020. No late applications will be accepted for this Funding Opportunity Announcement
• Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)
  (RFA-DK-20-004)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 1, 2020. No late applications will be accepted for this Funding Opportunity Announcement All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed)
  (RFA-NS-21-007)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): October 27, 2020
• Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
  (RFA-OH-21-004)
  National Institute for Occupational Safety and Health
  National Institute on Aging
  Application Receipt Date(s): December 8, 2020 On-time submission requires that electronic applications be error-free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 5:00 PM Eastern Time on the listed application due date. Applicant organizations are strongly encouraged to start the registration process at least 4 weeks prior to the application due date Note: HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).